CAPEK JOHN M 4
4 · ABBOTT LABORATORIES · Filed Feb 23, 2022
Insider Transaction Report
Form 4
CAPEK JOHN M
Executive Vice President
Transactions
- Award
Option (right to buy)
2022-02-18+72,342→ 72,342 totalExercise: $117.58From: 2023-02-18Exp: 2032-02-17→ Common Shares (72,342 underlying) - Award
Common shares without par value
2022-02-18+15,523→ 336,921 total
Footnotes (2)
- [F1]These shares represent a performance-based restricted stock award under the Abbott Laboratories 2017 Incentive Stock Program. The award has a 3-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The award includes the right to have shares withheld for tax purposes.
- [F2]Employee stock option granted pursuant to the Abbott Laboratories 2017 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 24,114 on February 18, 2023, 24,114 on February 18, 2024, and 24,114 on February 18, 2025.